These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pharmacology update. Anti-peptic ulcer agents--Part I. A histamine 2 receptor antagonist. Romankiewicz JA J Pract Nurs; 1981 Jan; 31(1):15-6. PubMed ID: 6108367 [No Abstract] [Full Text] [Related]
24. [Opinion on the drug treatment of peptic ulcer]. Tarpila S Duodecim; 1991; 107(22):1906-7. PubMed ID: 1365972 [No Abstract] [Full Text] [Related]
25. [The histoenzymological and ultrastructural changes in the gastric mucosa in peptic ulcer after treatment with pirenzepine and histamine H2-receptor blockaders]. Degtiareva II; Kharchenko NV; Lodianaia EV; Zukheĭr Kh; Tokar' DV; Nevstruev VP; Piletskiĭ AM Lik Sprava; 1995; (1-2):48-51. PubMed ID: 7483543 [TBL] [Abstract][Full Text] [Related]
26. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs]. László A Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001 [TBL] [Abstract][Full Text] [Related]
27. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2). Feldman M; Burton ME N Engl J Med; 1990 Dec; 323(25):1749-55. PubMed ID: 1978926 [No Abstract] [Full Text] [Related]
28. A practice-based approach for converting from proton pump inhibitors to less costly therapy. Lucas LM; Gerrity MS; Anderson T Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299 [TBL] [Abstract][Full Text] [Related]
29. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases]. Grebnev AL; Miagkova LP; Kkhorshed AM Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772 [No Abstract] [Full Text] [Related]
30. [Proton pump inhibitors in bleeding stomach ulcer?]. Schaffalitzky de Muckadell OB Ugeskr Laeger; 2006 Mar; 168(10):1024-6. PubMed ID: 16522294 [No Abstract] [Full Text] [Related]
31. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Vestergaard P; Rejnmark L; Mosekilde L Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047 [TBL] [Abstract][Full Text] [Related]
32. [Changed ulcer surgery in the era of H2-blockers]. Paimela H; Tuompo P; Peräkylä T; Saario I; Höckerstedt K; Kivilaakso E Duodecim; 1991; 107(6):435-40. PubMed ID: 1364891 [No Abstract] [Full Text] [Related]
33. Surgery for peptic ulcer disease in the era of H2 receptor blockers. Jamieson GG Dig Dis; 1989; 7(2):76-85. PubMed ID: 2566402 [No Abstract] [Full Text] [Related]
34. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists. Dhillo WS; Jayasena CN; Lewis CJ; Martin NM; Tang KC; Meeran K; Todd JF Ann Clin Biochem; 2006 Mar; 43(Pt 2):153-5. PubMed ID: 16536918 [TBL] [Abstract][Full Text] [Related]
35. [Non operative treatment for perforated peptic ulcer: results of a prospective study]. Songne B; Jean F; Foulatier O; Khalil H; Scotté M Ann Chir; 2004 Dec; 129(10):578-82. PubMed ID: 15581818 [TBL] [Abstract][Full Text] [Related]
36. [H2 blockers in a new dosage form: effect on the endocrine system?]. Müller P; Dammann HG; Simon B Med Klin (Munich); 1986 Jan; 81(2):45-8. PubMed ID: 2878357 [No Abstract] [Full Text] [Related]
37. [Pharmacoeconomics in the therapy of peptic ulcer]. Tesar T; Foltán V; Huorka M Ceska Slov Farm; 2002 Mar; 51(2):78-83. PubMed ID: 11928281 [TBL] [Abstract][Full Text] [Related]
38. [The use of histamine H2 receptor blockaders in gastroenterology]. Waldum HL; Petersen H Tidsskr Nor Laegeforen; 1983 Apr; 103(12):980-3. PubMed ID: 6136102 [No Abstract] [Full Text] [Related]
39. [Peptic ulcer: how to treat it long term]. Zaterka S; Bettarello A Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(1):1-3. PubMed ID: 2892245 [No Abstract] [Full Text] [Related]
40. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH. Tofil NM; Benner KW; Fuller MP; Winkler MK J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]